Management of coincident glaucoma and cataract.
The glaucoma combined procedure continues to evolve and improve. The use of antimetabolites as pharmacologic modulators of wound healing in conjunction with argon laser suture lysis and small-incision phacoemulsification techniques has revolutionized the glaucoma combined procedure. This discussion describes the current trends in the management of coincident glaucoma and cataract. The literature from the past year is reviewed with respect to this important topic. The role of antimetabolites in combined glaucoma surgery, the implications of the pseudoexfoliation syndrome, and the various options available for small pupil phacoemulsification are addressed. The intention is not to provide a comprehensive review of this topic but to discuss current opinion on the various issues that have been addressed in literature during the past year.
Samuelson
T W
TW
Phillips Eye Institute, Minneapolis, Minnesota, USA.
D002386:Cataract / Q000150:complications*; D002387:Cataract Extraction; D017889:Exfoliation Syndrome / Q000150:complications; D005472:Fluorouracil / Q000008:administration & dosage; D005901:Glaucoma / Q000150:complications* / Q000601:surgery*; D006801:Humans; D007910:Lenses, Intraocular; D016685:Mitomycin / Q000008:administration & dosage; D011680:Pupil / Q000502:physiology; D014130:Trabeculectomy; D014945:Wound Healing / Q000187:drug effects